Mannino Federica, Arcoraci Vincenzo, Vermiglio Giovanna, Labellarte Davide, Pirrotta Igor, Giorgi Domenico Antonio, Scarfone Alessandro, Bitto Alessandra, Minutoli Letteria, Vaccaro Mario, Galeano Mariarosaria, Pallio Giovanni, Irrera Natasha
Department of Medicine and Surgery, University of Enna "Kore", Contrada Santa Panasia, 94100 Enna, Italy.
Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.
Pharmaceuticals (Basel). 2024 Jul 25;17(8):986. doi: 10.3390/ph17080986.
Obesity is considered one of the main risk factors for cardiovascular diseases. The browning process has been recently recognized as a promising anti-obesity therapy. Lycopene (LYC) and fruit extract (GE) might be important resources for anti-obesity drugs; therefore, the aim of this study was to investigate the anti-obesity effects of LYC and GE on 3T3-L1 adipocytes and Zucker rats. Mouse 3T3-L1 pre-adipocytes were differentiated in mature adipocytes and then treated with LYC (0.5 μM), GE (30 mg/mL) or LYC + GE for 24 h. Moreover, male Zucker Crl:ZUC-Leprfa rats were randomly assigned to 5 groups of 10 animals to orally receive Vehicle (Ctrl), Orlistat (20 mg/kg), LYC (5 mg/kg), GE (1000 mg/kg) or LYC + GE for 28 days. LYC, GC extracts and even more LYC + GE stimulated the mRNA and protein expression of thermogenic genes , and , significantly reduced lipid droplet size and increased lipid droplet number in adipocytes. UCP1 mRNA and protein expression was also increased in the visceral adipose tissue of the rats that received the dietary intake of LYC, GE and even more LYC + GE. Moreover, LYC + GE induced the reorganization of visceral fat depots that showed a great number of small adipocytes and a significant reduction in weight gain and food intake compared to the control group. The obtained results demonstrated that LYC + GE might be used as new approaches for obesity management in order to induce the browning process and achieve a metabolically active tissue instead of a tissue characterized by lipid depot accumulation.
肥胖被认为是心血管疾病的主要危险因素之一。近年来,褐变过程被认为是一种有前景的抗肥胖疗法。番茄红素(LYC)和水果提取物(GE)可能是抗肥胖药物的重要资源;因此,本研究的目的是探讨LYC和GE对3T3-L1脂肪细胞和 Zucker 大鼠的抗肥胖作用。将小鼠3T3-L1前脂肪细胞分化为成熟脂肪细胞,然后用LYC(0.5 μM)、GE(30 mg/mL)或LYC + GE处理24小时。此外,将雄性 Zucker Crl:ZUC-Leprfa大鼠随机分为5组,每组10只动物,口服给予溶媒(对照)、奥利司他(20 mg/kg)、LYC(5 mg/kg)、GE(1000 mg/kg)或LYC + GE,持续28天。LYC、GC提取物以及LYC + GE更能刺激产热基因 、 的mRNA和蛋白表达,显著减小脂肪细胞中脂滴大小并增加脂滴数量。在接受LYC、GE饮食摄入以及LYC + GE的大鼠内脏脂肪组织中,UCP1 mRNA和蛋白表达也增加。此外,与对照组相比,LYC + GE诱导内脏脂肪库重组,表现为大量小脂肪细胞,体重增加和食物摄入量显著减少。所得结果表明,LYC + GE可能作为肥胖管理的新方法,以诱导褐变过程并实现代谢活跃的组织,而不是以脂质储存积累为特征的组织。